CleanGo Innovations Subsidiary Kubera to Acquire Italian Pharmaceutical Firm Freia Farmaceutici

CleanGo Innovations Inc., a Canadian publicly traded company focused on environmentally sustainable cleaning solutions, announced through its wholly-owned subsidiary Kubera Black Technology Inc. that it has entered a non-binding letter of intent to acquire Italian pharmaceutical company Freia Farmaceutici Srl. The proposed transaction represents a strategic expansion into the global health sector for CleanGo, leveraging Freia's expertise in plant-based therapeutic solutions.

Freia Farmaceutici, established in 2009 and headquartered in Milan, Italy, has built a reputation as a leader in vegetable omegas and plant-derived therapeutic assets. The company develops non-drug therapeutic solutions including medical devices containing bioactive substances, nutritional supplements, and food for special medical purposes. Their approach aligns with growing consumer awareness of well-being and disease prevention, offering solutions from vegetable sources with no known side effects.

The company's scientific focus includes significant work with plant-based omega oils, particularly through its ALFALIFE brand which possesses anti-inflammatory properties with applications in cardiovascular diseases, obesity, and child neuropsychiatry. Freia's Dermolife line includes products registered as Class IIA Medical Devices for dermatological conditions such as radiodermatitis prevention and treatment, atopic dermatitis, and scar remodeling. Through its PROMEDIAL brand, developed in partnership with leading international companies since 2016, Freia offers solutions for healthy skin and aesthetic medicine purposes.

Financially, Freia reported gross revenue exceeding €3.1 million in 2024, with all revenue generated in the Italian market, resulting in a net positive balance sheet. The company is on pace to exceed its 2024 revenue numbers in 2025. According to the press release available at https://www.newmediawire.com, Freia's strategic expansion plans include moving into other European markets, and with this transaction, the company gains immediate access to Canadian and U.S. markets through the resulting issuer's corporate structure.

The transaction terms outlined in the December 9, 2025 letter of intent indicate that Freia shareholders will exchange their outstanding securities for a maximum of twenty-five million common shares in Kubera. Following the proposed transaction, the resulting company will continue Freia's business and aims to complete a subsequent equity financing to satisfy business objectives for at least twelve months. The board of directors will consist of five members, with four nominated by Freia and one nominated by CleanGo, and no long-term debt will be assumed by Kubera under the current agreement.

Completion of the transaction is subject to satisfactory due diligence, negotiation of a definitive agreement within 45 days, and receipt of necessary board, shareholder, and regulatory approvals. For CleanGo Innovations, which trades on the Canadian Securities Exchange under symbol CSE: CGII, this acquisition represents an opportunity to integrate Freia's pipeline of innovative plant-based solutions into its portfolio, particularly in the growing nutraceutical and aesthetic medicine sectors. The move signals CleanGo's strategic diversification beyond its core business of non-toxic, biodegradable cleaning solutions for industrial markets into the health and wellness sector.